BridgeMD
New treatment option for Electronic Nicotine Delivery Systems
Official title Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
ClinicalTrials.gov ID: NCT06395415
What this study is testing
- What it's testing
- Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a promising avenue for intervention.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 26. Healthy volunteers may be eligible.
You may be able to join if
- Age 18-26 years old, ability to understand the English language, willing and able to provide informed consent
- Current ENDS user (at least 4 out of 7 days per week of use for the past one month); for focus groups, at least half of participants will report...
- Report interest in quitting or reducing ENDS (at least 6/10 scale in interest of quitting or reducing
- Does not currently (in past one year) meet criteria for major psychiatric disorder including severe alcohol or substance use disorder (excluding...
- For women, not currently pregnant, planning to become pregnant, or breastfeeding due to lack of information on ENDS use and possible harms from NRT...
You likely can't join if
- Does not own a mobile phone or is unwilling to receive text messages to their device
- No interest in quitting or reducing use of ENDS
- Uses electronic cigarettes less than 4 days per week in the past month
- Reports past-year serious psychiatric illness, including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia...
- Is currently using smoking cessation medication including Varenicline or Bupropion
- Are a female who is currently pregnant or nursing or planning to become pregnant within the next 6 months
See the full eligibility criteria
- Age 18-26 years old, ability to understand the English language, willing and able to provide informed consent
- Current ENDS user (at least 4 out of 7 days per week of use for the past one month); for focus groups, at least half of participants will report current cigarette smoking (at least 1 cigarette per day on at least 1 day...
- Report interest in quitting or reducing ENDS (at least 6/10 scale in interest of quitting or reducing
- Does not currently (in past one year) meet criteria for major psychiatric disorder including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia, bipolar disorder, and obsessive...
- For women, not currently pregnant, planning to become pregnant, or breastfeeding due to lack of information on ENDS use and possible harms from NRT during pregnancy
- Not currently using smoking cessation medication (i.e., Varenicline, Bupropion
- No history of adverse reactions to nicotine replacement therapy
- Does not own a mobile phone or is unwilling to receive text messages to their device
- No interest in quitting or reducing use of ENDS
- Uses electronic cigarettes less than 4 days per week in the past month
- Reports past-year serious psychiatric illness, including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia, bipolar disorder, and obsessive compulsive disorder
- Is currently using smoking cessation medication including Varenicline or Bupropion
- Are a female who is currently pregnant or nursing or planning to become pregnant within the next 6 months
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 26 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.